Literature DB >> 24523471

Association between norovirus and rotavirus infection and histo-blood group antigen types in Vietnamese children.

Nguyen Van Trang1, Hau ThiBich Vu, Nhung ThiHong Le, Pengwei Huang, Xi Jiang, Dang Duc Anh.   

Abstract

Norovirus and rotavirus are the two most important causes of acute gastroenteritis in children worldwide. Both norovirus and rotavirus recognize human histo-blood group antigens (HBGAs), and multiple binding patterns for HBGAs have been reported. To explore the role of HBGAs in host susceptibility to norovirus and rotavirus, we conducted a cross-sectional study in children hospitalized with diarrhea in northern Vietnam from September 2010 through September 2012. Of 260 children with paired stool and saliva samples, 158 (61%) were classified as HBGA secretors (Lea-b+), 31 (12%) were nonsecretors (Lea+b-), and 71 (27%) were partial secretors (Lea+b+). Norovirus was detected in 50 patients (19%), with viral genotypes GII.3 (n=28) and GII.4 (n=22) being the most common. All children infected with norovirus strains of genotype GII.4 were either HBGA secretors or partial secretors. Of the 28 GII.3 cases, 12 involved HBGA secretors, 11 partial secretors, and 5 nonsecretors. A total of 85 children tested positive for rotavirus, 74 of whom were infected with genotype P[8], 5 with P[4], and 6 with P[6]; all were HBGA secretors or partial secretors. This is the first epidemiological study demonstrating in a population that HBGA phenotype is a key susceptibility factor for both norovirus and rotavirus infections in children.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24523471      PMCID: PMC3993640          DOI: 10.1128/JCM.02927-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  49 in total

1.  Detection and molecular characterization of noroviruses and sapoviruses in children admitted to hospital with acute gastroenteritis in Vietnam.

Authors:  Nguyen V Trang; Le T Luan; Le T Kim-Anh; Vu T B Hau; Le T H Nhung; Pimmnapar Phasuk; Orntipa Setrabutr; Hannah Shirley; Jan Vinjé; Dang D Anh; Carl J Mason
Journal:  J Med Virol       Date:  2012-02       Impact factor: 2.327

Review 2.  Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic review.

Authors:  Kosuke Kawai; Megan A O'Brien; Michelle G Goveia; T Christopher Mast; Antoine C El Khoury
Journal:  Vaccine       Date:  2011-12-31       Impact factor: 3.641

3.  Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner.

Authors:  Pengwei Huang; Ming Xia; Ming Tan; Weiming Zhong; Chao Wei; Leyi Wang; Ardythe Morrow; Xi Jiang
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

4.  Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens.

Authors:  Yang Liu; Pengwei Huang; Ming Tan; Yiliu Liu; Jacek Biesiada; Jarek Meller; Alejandro A Castello; Baoming Jiang; Xi Jiang
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

5.  The importance of intergenic recombination in norovirus GII.3 evolution.

Authors:  Jackie E Mahar; Karin Bok; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

6.  Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans.

Authors:  Robert Frenck; David I Bernstein; Ming Xia; Pengwei Huang; Weiming Zhong; Susan Parker; Michelle Dickey; Monica McNeal; Xi Jiang
Journal:  J Infect Dis       Date:  2012-08-20       Impact factor: 5.226

7.  The emergence of rotavirus G12 and the prevalence of enteric viruses in hospitalized pediatric diarrheal patients in southern Vietnam.

Authors:  Phan Vu Tra My; Maia A Rabaa; Ha Vinh; Edward C Holmes; Nguyen Van Minh Hoang; Nguyen Thanh Vinh; Le Thi Phuong; Nguyen Thi Tham; Phan Van Be Bay; James I Campbell; Jeremy Farrar; Stephen Baker
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

8.  Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen.

Authors:  Liya Hu; Sue E Crawford; Rita Czako; Nicolas W Cortes-Penfield; David F Smith; Jacques Le Pendu; Mary K Estes; B V Venkataram Prasad
Journal:  Nature       Date:  2012-04-15       Impact factor: 49.962

9.  Two gastroenteritis outbreaks caused by GII Noroviruses: host susceptibility and HBGA phenotypes.

Authors:  Miao Jin; Yaqing He; Huiying Li; Pengwei Huang; Weiming Zhong; Hong Yang; Hailong Zhang; Ming Tan; Zhao-jun Duan
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

10.  Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland.

Authors:  Maria Hemming; Sirpa Räsänen; Leena Huhti; Minna Paloniemi; Marjo Salminen; Timo Vesikari
Journal:  Eur J Pediatr       Date:  2013-01-30       Impact factor: 3.183

View more
  52 in total

Review 1.  Role of histo-blood group antigens in primate enteric calicivirus infections.

Authors:  Karol Sestak
Journal:  World J Virol       Date:  2014-08-12

2.  Prevalence of rotavirus antibodies in breast milk and inhibitory effects to rotavirus vaccines.

Authors:  Nguyen V Trang; Tessa Braeckman; Tinne Lernout; Vu T B Hau; Le T K Anh; Le T Luan; Pierre Van Damme; Dang D Anh
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Both Lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype-dependent manner.

Authors:  Johan Nordgren; Sumit Sharma; Filemon Bucardo; Waqas Nasir; Gökçe Günaydın; Djeneba Ouermi; Leon W Nitiema; Sylvia Becker-Dreps; Jacques Simpore; Lennart Hammarström; Göran Larson; Lennart Svensson
Journal:  Clin Infect Dis       Date:  2014-08-05       Impact factor: 9.079

Review 4.  Current tools for norovirus drug discovery.

Authors:  Sahani Weerasekara; Allan M Prior; Duy H Hua
Journal:  Expert Opin Drug Discov       Date:  2016-05-02       Impact factor: 6.098

5.  Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice.

Authors:  Ming Xia; Pengwei Huang; Xi Jiang; Ming Tan
Journal:  Vaccine       Date:  2019-06-11       Impact factor: 3.641

6.  Innate Susceptibility to Norovirus Infections Influenced by FUT2 Genotype in a United States Pediatric Population.

Authors:  Rebecca L Currier; Daniel C Payne; Mary A Staat; Rangaraj Selvarangan; S Hannah Shirley; Natasha Halasa; Julie A Boom; Janet A Englund; Peter G Szilagyi; Christopher J Harrison; Eileen J Klein; Geoffrey A Weinberg; Mary E Wikswo; Umesh Parashar; Jan Vinjé; Ardythe L Morrow
Journal:  Clin Infect Dis       Date:  2015-03-05       Impact factor: 9.079

7.  Accumulation and Depuration Kinetics of Rotavirus in Mussels Experimentally Contaminated.

Authors:  Maria Grazia Amoroso; Antonio Luca Langellotti; Valeria Russo; Anna Martello; Marina Monini; Ilaria Di Bartolo; Giovanni Ianiro; Denise Di Concilio; Giorgio Galiero; Giovanna Fusco
Journal:  Food Environ Virol       Date:  2019-11-06       Impact factor: 2.778

8.  Human VP8* mAbs neutralize rotavirus selectively in human intestinal epithelial cells.

Authors:  Ningguo Feng; Liya Hu; Siyuan Ding; Mrinmoy Sanyal; Boyang Zhao; Banumathi Sankaran; Sasirekha Ramani; Monica McNeal; Linda L Yasukawa; Yanhua Song; B V Venkataram Prasad; Harry B Greenberg
Journal:  J Clin Invest       Date:  2019-08-12       Impact factor: 14.808

Review 9.  Developments in understanding acquired immunity and innate susceptibility to norovirus and rotavirus gastroenteritis in children.

Authors:  Daniel C Payne; Umesh D Parashar; Benjamin A Lopman
Journal:  Curr Opin Pediatr       Date:  2015-02       Impact factor: 2.856

10.  Naturally Acquired Immunity Against Rotavirus Infection and Gastroenteritis in Children: Paired Reanalyses of Birth Cohort Studies.

Authors:  Joseph A Lewnard; Benjamin A Lopman; Umesh D Parashar; Naor Bar-Zeev; Prasanna Samuel; M Lourdes Guerrero; Guillermo M Ruiz-Palacios; Gagandeep Kang; Virginia E Pitzer
Journal:  J Infect Dis       Date:  2017-08-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.